Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

16.670
-0.070-0.42%
Volume:2.99M
Turnover:49.73M
Market Cap:52.03B
PE:6.19
High:16.810
Open:16.810
Low:16.490
Close:16.740
52wk High:21.258
52wk Low:14.550
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:0.67
T/O Rate:0.22%
Dividend:0.79
Dividend Rate:4.74%
EPS(LYR):2.691
ROE:7.97%
ROA:2.56%
PB:0.51
PE(LYR):6.19
PS:0.08

Loading ...

SINOPHARM: CITIC Securities Company Limited Disposes of Shares, Long Position Falls to 9.97%

HK Disclosure
·
Nov 10

Sinopharm Group Stock Slides 0.6% in Hong Kong

Dow Jones
·
Nov 10

Sinopharm Renews Five Agreements With CNPGC

MT Newswires Live
·
Nov 10

Sinopharm Group Signs Three-Year Supply Purchase Agreement with CNPGC

Reuters
·
Nov 09

SINOPHARM: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 4.98%

HK Disclosure
·
Nov 09

SINOPHARM: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 5.02%

HK Disclosure
·
Nov 09

SINOPHARM: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 4.99%

HK Disclosure
·
Nov 06

Sinopharm Group Stock Advances 1.1% in Hong Kong

Dow Jones
·
Nov 06

Lazard Asset Management LLC Raises Stake in Sinopharm by About 5.3977 Million Shares at HK$16.19 Each

Stock News
·
Nov 05

SINOPHARM: Lazard Asset Management LLC Acquires Shares, Long Position Rises to 14.26%

HK Disclosure
·
Nov 05

JPMorgan Raises Stake in SINOPHARM (01099) by About 1.155 Million Shares at Roughly HK$16.14 Each

Stock News
·
Nov 04

SINOPHARM: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 5.04%

HK Disclosure
·
Nov 04

SINOPHARM: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 4.98%

HK Disclosure
·
Nov 03

Sinopharm Group Stock Rallies 2.4% in Hong Kong

Dow Jones
·
Nov 03

China NT Pharma Seeks Court Revocation of RMB 92 Million Arbitration Award

Reuters
·
Oct 30

Sinopharm Accord Posts 18.9% YoY Net Profit Growth in Q3 2026 as Revenue Edges Up 2.6%

Bulletin Express
·
Oct 30

Sinopharm Group (SEHK:1099) Could Be 3% Undervalued After Mixed Third Quarter Results

Simply Wall St.
·
Oct 28

CICC Retains Outperform Rating on SINOPHARM with HK$21.25 Target Price, 1Q-3Q26 Results In Line with Expectations

Stock News
·
Oct 28

Sinopharm Group Stock Advances 2.3% in Hong Kong

Dow Jones
·
Oct 27

Citi Raises Sinopharm Target Price to HK$20.5, Q3 Net Profit Slightly Beats Expectations, Maintains Buy Rating

Stock News
·
Oct 27